February 17, 2026
In an era of unprecedented scientific advancement, the intersection of medical innovation, evolving policy and patient access has never been more critical. The latest episode of GCI Health’s podcast, “Health Matters,” dives deep into this intricate landscape, featuring a conversation with John O’Brien, Pharm.D., MPH, President and CEO of the National Pharmaceutical Council. A pharmacist, caregiver and seasoned industry advisor, O’Brien blends his professional and personal insights to illuminate the path toward a healthcare system where every patient can truly benefit from life-changing medical breakthroughs.
O’Brien describes our current moment as a “golden age of biopharmaceutical innovation,” where treatments once considered science fiction are now realities. Yet, this incredible progress often collides with outdated reimbursement structures, leading to a system that views medicine from a financial perspective rather than for its profound impact on human lives. This episode tackles persistent misperceptions around drug pricing, the often misunderstood economics of pharmaceutical research and development, and how U.S. spending compares globally.
The conversation further explores the disconnect between how policymakers conceptualize the value of innovation and how patients experience it, highlighting that innovation only matters if it is accessible to those who stand to benefit from it. With discussions around new direct-to-patient models and recent legislative changes, O’Brien offers a vision for how government and business can work toward a system that truly serves patients.
Listen to the full episode here.